Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000665716 | SCV000789880 | uncertain significance | Peroxisome biogenesis disorder type 3B; Peroxisome biogenesis disorder 3A (Zellweger) | 2017-02-24 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000728569 | SCV000856161 | uncertain significance | not provided | 2018-04-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001035823 | SCV001199161 | uncertain significance | Peroxisome biogenesis disorder 3A (Zellweger) | 2022-05-06 | criteria provided, single submitter | clinical testing | This variant, c.182_184dup, results in the insertion of 1 amino acid(s) of the PEX12 protein (p.Glu61_Ile62insLys), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PEX12-related conditions. ClinVar contains an entry for this variant (Variation ID: 550849). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |